Recro Pharma, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Recro Pharma, Inc.
Stock-and-cash deal valued at $229m brings AzurRx rights to niclosamide in additional indications. Boehringer Ingelheim partners with Twist on therapeutic antibody discovery.
EQT and Goldman Sachs to pay $8.5bn in Parexel’s second private equity buyout in four years.
Contract research organization leaders weigh in on how to avoid some recent pitfalls seen at US FDA advisory committee panels.
The ‘sea change’ inside White Oak should be seen as very encouraging for sponsors, FDA official says.
- Contract Manufacturing Organization
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Baudax Bio, Inc.
- Recro Gainesville